USE OF THE COMPOUND 3-(4-AMINO-1-OXO - 1,3 -DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE - 2,6 DIONE IN PREPARING A PHARMACEUTICAL COMPOSITION FOR TREATING MULTIPLE MYELOMA IN COMBINATION WITH A SECOND ACTIVE INGREDIENT COMPRISING DEXAMETHASONE
Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the administration of an immunomodulatory compound alone or in combination with a second active ingredient. The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy which comprise the administration of an immunomodulatory compound. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed. In a specific embodiment, the cancer is lymphoma.
